Yes, that is one of the key advantages of combining ELISA with qPCR. You can measure extracellular CCL24 protein and compare it with intracellular mRNA changes from matched samples. This is particularly useful when treatments alter secretion pathways, protein stability, or feedback signaling. By presenting both readouts, you can better support mechanistic claims and reduce ambiguity when protein and mRNA levels do not track perfectly.
A streamlined approach is to collect supernatant for ELISA first, then immediately lyse or stabilize the corresponding cells for RNA extraction. Consistent timing is important so both readouts reflect the same biological state. We also recommend planning time points in advance and freezing aliquots to avoid repeated freeze-thaw cycles. If you share your stimulation duration and sample count, we can suggest a practical batch-processing schedule.
This pattern can occur due to post-transcriptional regulation, delayed secretion, protein degradation, or assay-range issues. First, verify ELISA dilution and ensure samples fall in the linear range; then consider collecting additional time points to capture secretion lag. For qPCR, confirm housekeeping gene stability and RNA quality. If you share your time points and treatment type, we can propose targeted checks to determine whether the discrepancy is biological or technical.
For Research Use Only. Do Not Use in Food Manufacturing or Medical Procedures (Diagnostics or Therapeutics). Do Not Use in Humans.